Welcome
Support Centre
23 May 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ Print-friendly version ]
Inguinal Hernia Study Using Surgisis IHM
Link to the ClinicalTrials.gov recordInformation obtained from ClinicalTrials.gov on February 23, 2012
Title of trial/grant titleInguinal Hernia Study Using Surgisis IHM
Current status of trialActive, not recruiting
Sponsors and collaboratorsCook
Cook Biotech Incorporated
MED Institute, Incorporated
Information provided byCook
ClinicalTrials.gov identifierNCT00393887
PurposeAim is to evaluate outcomes of inguinal hernia repair incorporating the standard
Lichtenstein (open) repair using Surgisis IHM in a double blind (physician evaluator and
patient will be blinded), randomized, prospective comparative study with polypropylene mesh.
Outcomes are recurrence, return to full activities, pain, seroma rates and complications.
Patients will be followed at 2 weeks, 3 months, and 6 months post-operatively, and every 6
months after that for 3 years. Hernia recurrence will be confirmed via ultrasound or CT
scan.
Condition(s)Inguinal Hernia
Intervention(s)Device: Surgisis IHM
Device: Prolene
PhaseN/A
Study type and designAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Official titleInguinal Hernia Study: A Double Blinded Randomized Prospective Study
Primary outcomeRecurrence rate 3 years No
Secondary outcomeTime back to baseline and complications 3 years Yes
Study startMarch 2007
Minimum age18 Years
Maximum ageN/A
GenderBoth
Eligibility criteriaInclusion Criteria:

- 18 years of age

- Diagnosis of Unilateral inguinal hernia repair

- Able to provide written consent

Exclusion Criteria:

- Incarcerated hernia

- Allergic or religious beliefs that disallow porcine material

- Previous hernia repair on the designated hernia site

- Class IV or V anesthesia requirements

- Bowel obstruction

- Peritonitis

- Life expectancy < 3 years
Study chairs or principal investigatorsAjay Jain, M.D., Principal Investigator, University of Maryland
LocationsMaryland, United States

University of Maryland
Baltimore
Maryland
21201
Study ID numbersH-28044; 05-003
Last updatedDecember 14, 2011
Record first receivedOctober 26, 2006
ClinicalTrials.gov identifierNCT00393887
Download dateInformation obtained from ClinicalTrials.gov on February 23, 2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement | cookies


BioMed Central